Chronic Fatigue Syndrome Will Be First Of PDUFA V’s Disease Area Meetings
From BioPharma Today
March 11, 2013 - 5:10pm
FDA is bringing an ongoing program to spur drug development for CFS and myalgic encephalomyelitis under the umbrella of the user fee program’s Patient-Focused Drug Development initiative, which calls for 20 patient-centric meetings over five years.
Continue reading this article »
Share This Article: